Back to 
Bank of New York Mellon Corp
Bank of New York Mellon Corp
SNDXShowing 8 of 28 quarters
Position history for Bank of New York Mellon Corp's holdings in SYNDAX PHARMACEUTICALS INC
Yes. Bank of New York Mellon holds 1,040,079 shares of SNDX (Syndax Pharmaceuticals), worth $22.7M, as of its Q2 2026 13F filing. It increased the position by 35,581 shares (+3.5%) from Q1 2026. Bank of New York Mellon has held SNDX in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$22.7M
Current Shares
1M
Total Value Change
+$18.5M
Total Shares Change
+818,577
Quarter-by-Quarter History
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., BlackRock Finance, Inc.